Physician

Preparation and integration support

Cluster covering 31 related competencies including: Integration support, Integration therapy, Integration coaching.

8 care stages · 83 guidelines · 14 courses · 13 providers

Acute psychological response and emergency management during dosing

Cluster covering 35 related competencies for monitoring acute psychological effects, recognising and managing distress, crisis containment, emergency escalation, and rescue-medication coordination during psychedelic dosing sessions.

8 care stages · 69 guidelines · 2 courses · 2 providers

Adverse event identification, documentation, and reporting

Teaches how to detect, elicit, document, and report adverse events and serious adverse events across the participant journey. The focus is accurate source documentation, regulatory reporting discipline, follow-up, and preservation of participant safety and trial integrity.

7 care stages · 67 guidelines · 0 courses · 0 providers

Suicide and serious psychiatric risk assessment

Teaches structured assessment of suicidal ideation, intent, psychiatric deterioration, and related high-risk presentations. Learners are trained to use appropriate tools, safety planning, emergency contacts, clinician access, and escalation pathways when risk is identified.

7 care stages · 66 guidelines · 1 courses · 1 providers

Screening, eligibility, and readiness assessment

Teaches how to assess clinical suitability before psychedelic or ketamine treatment, including medical and psychiatric screening, readiness evaluation, contraindication review, inclusion/exclusion criteria, and ongoing eligibility re-checks before dosing.

8 care stages · 64 guidelines · 12 courses · 10 providers

Manual fidelity, protocol adherence, and deviation management

Teaches faithful delivery of manualized treatment and protocol-defined procedures while documenting and managing unavoidable deviations. The competency protects participant welfare, treatment consistency, data integrity, and sponsor oversight.

8 care stages · 61 guidelines · 0 courses · 0 providers

Post-dose follow-up, safety monitoring, and retention support

Teaches ongoing participant contact after dosing to support stability, detect delayed adverse effects, maintain therapeutic containment, and sustain adherence to follow-up visits and outcome assessments.

7 care stages · 60 guidelines · 0 courses · 0 providers

Emergency recognition, escalation, and disposition planning

Teaches recognition of medical or psychiatric emergencies and the steps required to escalate care safely. The competency includes de-escalation, clinical consultation, 911 or emergency department transfer, serious-event escalation, and referral to appropriate higher-level care.

7 care stages · 49 guidelines · 3 courses · 3 providers

Discharge readiness, escort safety, and post-session supervision

Teaches how to determine when a participant is safe to leave after dosing and how to arrange appropriate supervision afterward. The competency covers psychological and physical stability, escort/support-person coordination, discharge restrictions, overnight or post-session support, and follow-up contact when needed.

8 care stages · 44 guidelines · 0 courses · 0 providers

Medication, substance-use, washout, and taper management

Teaches review and management of concomitant medications, restricted therapies, prohibited substances, washout periods, tapering requirements, and abstinence expectations. The competency includes participant counseling, medication reconciliation, sponsor notification, and team coordination when restrictions affect safety or interpretability.

7 care stages · 40 guidelines · 0 courses · 0 providers

Blinding, allocation concealment, and unblinding control

Teaches how to preserve blinded trial conduct across participant interactions, outcome collection, staff roles, and session procedures. The competency includes preventing accidental unblinding, minimizing bias, and using emergency unblinding only when clinically necessary.

8 care stages · 37 guidelines · 0 courses · 0 providers

Co-therapist and multidisciplinary team coordination

Teaches coordinated practice across co-therapists, physicians, psychiatrists, study coordinators, principal investigators, and other care-team members. The focus is shared responsibility, clear communication, role clarity, and coordinated observation of participant status.

8 care stages · 36 guidelines · 0 courses · 0 providers

Good Clinical Practice and protocol procedure compliance

Teaches adherence to Good Clinical Practice, assigned study roles, protocol procedures, delegation boundaries, and applicable research regulations. The competency supports consistent execution of approved procedures across sites and participants.

7 care stages · 34 guidelines · 0 courses · 0 providers

Therapeutic boundaries, professional conduct, and consent for touch

Teaches how to maintain clear relational and physical boundaries in emotionally vulnerable treatment settings. This includes professional conduct, rapport without overreach, explicit consent for touch, the right to revoke consent, and strict prohibition of sexual or erotic contact.

8 care stages · 30 guidelines · 1 courses · 1 providers

Acute psychiatric and behavioral risk monitoring

Teaches continuous monitoring for distress, confusion, psychotic symptoms, suicidality, agitation, and other acute behavioral risks during and after dosing. The focus is early recognition, documentation, and escalation to clinical support when risk emerges.

7 care stages · 30 guidelines · 0 courses · 0 providers

Physical safety monitoring

Cluster covering 3 related competencies including: Physical safety monitoring, Safety monitoring during dosing sessions, Medical safety monitoring during psilocybin administration.

6 care stages · 29 guidelines · 0 courses · 0 providers

Psychological support during altered states

Provides supportive therapeutic presence while the patient is under the influence of ketamine. Uses calming, noncoercive guidance to help the patient navigate dissociation and emotional material.

8 care stages · 28 guidelines · 0 courses · 0 providers

Psychedelic-assisted psychotherapy preparation and integration

Teaches structured pre-dose preparation and post-dose integration as the therapeutic frame for psychedelic-assisted psychotherapy. The therapist supports rapport, intention clarification, meaning-making, emotional processing, and consolidation of insights after dosing.

8 care stages · 22 guidelines · 2 courses · 2 providers

Ethical conduct in human-subject research

Able to practice ethically in a clinical trial environment involving a Schedule-sensitive psychoactive intervention. This includes protecting participants, adhering to protocol, and supporting valid informed participation.

7 care stages · 22 guidelines · 0 courses · 0 providers

Physiologic monitoring, thermoregulation, hydration, and overdose response

Teaches monitoring and response for acute physiological risks, including vital signs, temperature, hydration, overheating, excessive fluid intake, and suspected overdose. The competency emphasizes supportive care, medical coordination, documentation, and escalation when needed.

6 care stages · 22 guidelines · 0 courses · 0 providers

Comprehensive psychiatric assessment

Ability to perform or supervise detailed psychiatric evaluation for diagnosis, eligibility, and ongoing monitoring. The therapist/facilitator must understand symptom presentations relevant to MDD, AUD, suicidality, psychosis, and dissociation.

7 care stages · 20 guidelines · 0 courses · 0 providers

Risk screening and exclusion judgment

Know the medical and psychiatric exclusions that protect participants from foreseeable harm. Facilitators must recognize conditions that make MDMA-assisted psychotherapy unsafe or inappropriate.

7 care stages · 20 guidelines · 0 courses · 0 providers

Adverse effects and side-effect management

Teaches recognition and management of expected and unexpected side effects during psychedelic or ketamine treatment. The competency emphasizes active observation, supportive response, and clinical escalation when symptoms exceed routine tolerability.

6 care stages · 18 guidelines · 0 courses · 0 providers

Psilocybin session facilitation

Cluster covering 9 related competencies including: Psilocybin facilitation, Psilocybin session support, Psilocybin facilitation basics.

8 care stages · 17 guidelines · 6 courses · 5 providers

Mindfulness, intention-setting, set and setting, and somatic presence

Teaches practices that support preparation and therapeutic presence, including mindfulness, intention-setting, body-aware attention, environmental preparation, mindset awareness, and regulation through somatic presence.

7 care stages · 16 guidelines · 5 courses · 5 providers

Hallucinogen pharmacology and effects

Cluster covering 7 related competencies including: Physiologic safety awareness, Hallucinogen pharmacology and effects, Hallucinogen-assisted therapy knowledge.

8 care stages · 16 guidelines · 0 courses · 0 providers

Special-interest adverse event vigilance

The protocol requires active monitoring for psychedelic-specific adverse events such as hallucinations, psychotic symptoms, dissociation, mood alteration, and cognitive disturbance. These require immediate notification and follow-up.

7 care stages · 16 guidelines · 0 courses · 0 providers

Ketamine psychotherapy delivery

Cluster covering 12 related competencies including: KAP psychotherapy delivery, Ketamine and KAP knowledge, Ketamine integration planning.

8 care stages · 15 guidelines · 5 courses · 4 providers

Dose escalation decision support

The therapist/facilitator must support structured dose escalation decisions within the individualized dosing regimen. Decisions depend on both patient-reported peak experience and clinical tolerability/safety judgments.

4 care stages · 15 guidelines · 0 courses · 0 providers

Continuation, discontinuation, and risk-benefit judgment

Teaches how clinicians determine whether a participant should proceed, pause, discontinue dosing, or terminate study participation. The competency centers on safety-driven clinical judgment, risk-benefit assessment, and early termination when continuation is no longer appropriate.

6 care stages · 14 guidelines · 0 courses · 0 providers

Dissociation and acute neuropsychiatric effect monitoring

Teaches recognition and documentation of dissociation, psychosis-like symptoms, mania, and other acute neuropsychiatric effects that can occur after ketamine, psychedelic dosing, or related interventions. The focus is monitoring, reporting, and escalation when symptoms become clinically significant.

7 care stages · 14 guidelines · 0 courses · 0 providers

Participant safety restriction counseling

Teaches how to instruct participants on post-dose and study-period restrictions that reduce risk from impaired judgment, unsafe activity, prohibited substances, or behaviors that could confound study outcomes.

6 care stages · 13 guidelines · 0 courses · 0 providers

Cultural humility, Indigenous respect, and equity-oriented care

Teaches culturally responsive psychedelic care, including humility, anti-bias practice, Indigenous and traditional-use awareness, cultural appropriation concerns, diversity and inclusion, and respectful work with marginalized communities.

8 care stages · 12 guidelines · 8 courses · 8 providers

Medical escalation and rescue medication coordination

Cluster covering 2 related competencies including: Medical escalation and rescue medication use, Medical escalation and rescue medication coordination.

5 care stages · 11 guidelines · 0 courses · 0 providers

Participant-centered discharge planning and aftercare

Support decision-making about ongoing treatment after trial completion, particularly for participants who received escitalopram. The clinician helps participants consider whether to continue, taper, or return to usual care.

5 care stages · 10 guidelines · 0 courses · 0 providers

Vital sign and physical distress monitoring

Monitors participant physical status during study visits and identifies concerning changes requiring escalation. Vital signs and symptomatic changes are part of routine safety observation.

6 care stages · 10 guidelines · 0 courses · 0 providers

Psilocybin psychotherapy framework

Cluster covering 4 related competencies including: Psychedelic therapy workflow, Psilocybin psychotherapy framework, Psilocybin-assisted psychotherapy framework.

8 care stages · 9 guidelines · 2 courses · 1 providers

Risk evaluation and safety monitoring

Teaches continuous evaluation of clinical risk and maintenance of a safe care environment throughout preparation, dosing, and follow-up. Learners monitor risk signals, apply safety procedures, and escalate care when needed.

8 care stages · 9 guidelines · 2 courses · 1 providers

Management of psychological distress

Facilitators must be able to contain and support intense psychological distress during the session. The study notes that the experience could be emotionally difficult even when participants felt safe.

7 care stages · 9 guidelines · 0 courses · 0 providers

Provide overnight and next-day containment

Therapists must ensure continuity of care after the acute session, including overnight observation and next-morning integration before discharge. This reflects a containment and recovery responsibility beyond the dosing period.

5 care stages · 9 guidelines · 0 courses · 0 providers

Safety escalation and collaboration

Knows when to involve physicians, psychologists, and independent safety oversight. Complex psychedelic sessions require clear escalation pathways and team coordination.

7 care stages · 9 guidelines · 0 courses · 0 providers

Physiologic monitoring during ketamine administration

Cluster covering 2 related competencies including: Safety monitoring during ketamine dosing, Physiologic monitoring during ketamine administration.

6 care stages · 8 guidelines · 0 courses · 0 providers

Substance use assessment

Ability to evaluate alcohol and other substance use patterns using standardized tools and clinical interview. This is essential for eligibility, safety, and outcome monitoring.

6 care stages · 8 guidelines · 0 courses · 0 providers

Ethical psychedelic facilitation

Cluster covering 3 related competencies including: Ethical psychedelic facilitation, Safe, legal psychedelic care facilitation, Ethical decision-making in psychedelic facilitation.

8 care stages · 7 guidelines · 2 courses · 2 providers

Management of concomitant medication interactions

Cluster covering 5 related competencies including: Concomitant medication review, Contraindication and interaction awareness, Contraindications, drug effects, and interactions.

5 care stages · 7 guidelines · 1 courses · 1 providers

Crisis and adverse-event response

The page signals training in managing difficult or high-risk moments, including crisis intervention and trigger management. Learners are expected to respond appropriately when a session becomes destabilizing or unsafe.

7 care stages · 7 guidelines · 0 courses · 0 providers

Knowledge of MDMA effects and risks

Facilitators must understand the expected psychological, physiological, and potential adverse effects of MDMA in order to prepare participants, support the session, and detect complications.

5 care stages · 7 guidelines · 0 courses · 0 providers

Nonintrusive session monitoring and containment

Facilitators must balance active safety monitoring with minimal interference in the participant’s inner experience. The role includes maintaining continuous presence, periodic check-ins, and preserving the therapeutic container of the session.

5 care stages · 7 guidelines · 0 courses · 0 providers

Preparatory psychotherapy competence

Conduct preparatory sessions that orient the subject, assess readiness, and set expectations for MDMA-assisted psychotherapy. These sessions are used to prepare for safety, adherence, and therapeutic engagement.

7 care stages · 7 guidelines · 0 courses · 0 providers

Prioritize participant wellbeing over research aims

Participant safety and wellbeing must take precedence over scientific objectives at all times. Therapists must communicate and operationalize this priority throughout screening, treatment, and follow-up.

4 care stages · 7 guidelines · 0 courses · 0 providers

Independent outcome assessment administration

The facilitator must administer and coordinate patient-rated and clinician-rated measures while minimizing bias. Assessments should be completed independently and in the correct order.

4 care stages · 6 guidelines · 0 courses · 0 providers

Medication taper and withdrawal monitoring

Teaches monitoring during down-titration or discontinuation of psychiatric medications before dosing. Learners track withdrawal symptoms, symptom worsening, suicidality, and other risks that may emerge during tapering.

4 care stages · 6 guidelines · 0 courses · 0 providers

Use clear, participant-centered communication

Therapists should communicate in language and nonverbal style the participant can readily follow, avoiding overly theoretical or confusing discourse.

5 care stages · 6 guidelines · 0 courses · 0 providers

Competence in specialized psychedelic therapy training

The protocol implies that facilitators should have specific psychiatric, psychotherapeutic, or psycholytic therapy training relevant to altered-state treatment. Specialized experience supports safe and effective delivery of LSD-assisted psychotherapy.

6 care stages · 5 guidelines · 0 courses · 0 providers

Management of dual relationships and undue influence

Therapists must protect voluntariness when potential participants are also their patients. Independent evaluation should be used to reduce pressure or perceived coercion in recruitment and consent.

5 care stages · 5 guidelines · 0 courses · 0 providers

Professional licensure and supervision

Therapists must meet licensure requirements and work within supervision structures appropriate to their training and role. Unlicensed or PAP-inexperienced staff require direct supervision.

3 care stages · 5 guidelines · 0 courses · 0 providers

Professional qualification and supervised practice

Lead therapists must hold appropriate licensure and regulatory registration to provide psychotherapy, and have prior PAP experience. Unlicensed or inexperienced therapists may participate only under direct supervision.

3 care stages · 5 guidelines · 0 courses · 0 providers

Professional qualifications and experience threshold

The manual specifies baseline professional requirements for study therapists. These include licensure and substantial clinical experience with psychiatric populations.

3 care stages · 5 guidelines · 0 courses · 0 providers

Team communication and escalation pathways

Coordinate effectively with the study clinician, medical monitor, rater team, and MRI staff. Facilitation is embedded in a broader clinical-research workflow requiring timely communication.

7 care stages · 5 guidelines · 0 courses · 0 providers

Professional self-care and burnout prevention

Teaches sustainable self-care practices for clinicians and facilitators working in emotionally intense settings. The competency supports emotional resilience, ethical boundaries, reflective practice, and burnout prevention.

6 care stages · 4 guidelines · 3 courses · 3 providers

Professional Scope and Practice Alignment

Teaches clinicians to recognise their role boundaries, align services with training, licensure, supervision, and organisational policy, and refer or escalate when participant needs fall outside their scope of competence.

6 care stages · 4 guidelines · 3 courses · 2 providers

Clinical supervision participation

Engages in ongoing supervision and accepts feedback to maintain treatment quality. Supports corrective action when performance is unsatisfactory.

4 care stages · 4 guidelines · 0 courses · 0 providers

Evaluate readiness and contraindications for subsequent sessions

After each MDMA session, therapists must assess whether continuing treatment is safe and clinically appropriate. The participant’s choice is respected unless safety concerns warrant exclusion.

5 care stages · 4 guidelines · 0 courses · 0 providers

Manage agitation and elopement risk

Respond to agitation or attempts to leave the room in a way that preserves safety for the patient and others. The therapist should use containment, redirection, and escalation protocols when needed.

4 care stages · 4 guidelines · 0 courses · 0 providers

Pre-treatment clinical risk assessment

Understand the major medical risks associated with ibogaine administration, especially cardiac and neurologic toxicity, before proceeding with treatment. This includes recognizing that ibogaine has been linked to torsades de pointes, QTc prolongation, bradycardia, and ataxia.

4 care stages · 4 guidelines · 0 courses · 0 providers

Pharmacology, contraindications, and interaction awareness

Teaches psychoactive substance pharmacology, expected drug effects, contraindications, and relevant drug-interaction risks. The competency supports safer screening, medication review, participant education, and clinical decision-making.

5 care stages · 3 guidelines · 1 courses · 1 providers

Collaboration with medical supervision

Therapists function within a medically supervised ketamine model and must coordinate closely with clinicians responsible for dosing oversight and safety clearance. This includes understanding role boundaries and supporting monitoring workflows.

3 care stages · 3 guidelines · 0 courses · 0 providers

Coordinate with outside providers ethically

Therapists must coordinate with prescribing clinicians and existing psychotherapists when relevant, while respecting consent and confidentiality. Communication should support safety, continuity, and protocol integrity.

3 care stages · 3 guidelines · 0 courses · 0 providers

MRI safety screening and imaging-session coordination

Teaches screening for MRI contraindications and coordination of imaging clearance before scan procedures. The competency prevents exposure of ineligible participants to magnetic-resonance risks and supports safe imaging-session logistics.

3 care stages · 3 guidelines · 0 courses · 0 providers

Nighttime and overnight participant support

When overnight stays are required, facilitators and attendants must maintain safe observation and supportive presence without acting as outside therapists. They need to monitor comfort, safety, and emergency access overnight.

4 care stages · 3 guidelines · 0 courses · 0 providers

Physiological and psychological observation during medicine sessions

Ability to observe and respond to participants during MDMA medicine sessions, including both psychological experience and physiological change. The protocol indicates an interest in psychological and physiological processes of change during treatment.

3 care stages · 3 guidelines · 0 courses · 0 providers

Protection against coercion and dual-role influence

The protocol explicitly addresses the risk of undue influence when investigators recruit current or former patients, requiring safeguards and ongoing monitoring for coercion.

4 care stages · 3 guidelines · 0 courses · 0 providers

Research rating fidelity

Ability to administer standardized clinical ratings consistently and under supervision. Reliable measurement is essential for efficacy and safety endpoints.

4 care stages · 3 guidelines · 0 courses · 0 providers

Harm reduction and risk awareness

Cluster covering 5 related competencies including: Harm-reduction orientation, Harm reduction and risk awareness, Harm reduction for client support.

8 care stages · 2 guidelines · 4 courses · 4 providers

Clinical protocol literacy

Teaches practitioners to read and understand clinical protocols, treatment manuals, and evidence-based psychedelic care procedures. The focus is knowing how protocol requirements shape preparation, dosing, integration, documentation, and safety responsibilities.

5 care stages · 2 guidelines · 2 courses · 2 providers

Legal and Regulatory Navigation

Teaches practitioners to identify and apply relevant legal, regulatory, ethical, and institutional requirements, including documentation, consent, reporting, controlled-substance, and jurisdiction-specific obligations.

7 care stages · 2 guidelines · 2 courses · 2 providers

Basic life support

Learners are explicitly offered Basic Life Support training, indicating emergency readiness and medical safety preparation. The page notes DORA-required status, signaling regulatory safety relevance.

4 care stages · 2 guidelines · 1 courses · 1 providers

Appropriate facilitator qualifications

Lead facilitators were doctoral-level psychologists or physicians with major depressive disorder treatment experience, and co-facilitators had at least a bachelor’s degree in a mental health-related field. The source therefore indicates role-appropriate clinical background and experience requirements.

3 care stages · 2 guidelines · 0 courses · 0 providers

Assessment of emotional stability after sessions

Therapists must remain with participants at the end of and immediately after experimental sessions until emotional stability is established. This requires real-time clinical judgment about readiness for reduced supervision.

3 care stages · 2 guidelines · 0 courses · 0 providers

Check-in and timing of interventions during sessions

Therapists must skillfully time check-ins and interventions to sustain process without unnecessary intrusion. They monitor silence, talking, avoidance, and signs of internal engagement to decide when to inquire, redirect, or simply witness.

3 care stages · 2 guidelines · 0 courses · 0 providers

Interprofessional coordination and referral management

Safe delivery requires coordination among therapists, physicians, nurses, blinded assessors, outside therapists, and emergency services.

4 care stages · 2 guidelines · 0 courses · 0 providers

On-site physician emergency competence

A study physician with psychiatric and cardiovascular emergency expertise must be available during dosing. This reflects a requirement for advanced emergency readiness and clinical judgment.

3 care stages · 2 guidelines · 0 courses · 0 providers

Overdose, misuse, and abuse-liability vigilance

Facilitators are expected to monitor for signs of misuse, diversion, dependence, or other abuse-related phenomena even though the medication is administered only on-site. They must also recognize protocol violations or dropout patterns that may signal abuse liability concerns.

4 care stages · 2 guidelines · 0 courses · 0 providers

Paranoia and psychotomimetic state management

The therapist must recognize confusion, paranoia, referential thinking, withdrawal, or grandiosity and respond with steady trust, containment, and continued presence. Management skill is particularly important because these reactions may still be workable and may shift with proper handling.

2 care stages · 2 guidelines · 0 courses · 0 providers

Pharmacokinetic understanding of ibogaine

Understand ibogaine, noribogaine, and noribogaine glucuronide disposition and how exposure relates to clinical effects. This knowledge supports safe interpretation of observed toxicity and response.

3 care stages · 2 guidelines · 0 courses · 0 providers

Reactivation event assessment

Identify and document possible post-dose reactivation or flashback-like experiences. The therapist must capture timing, context, emotional valence, and functional impact of these events.

3 care stages · 2 guidelines · 0 courses · 0 providers

Shared decision-making and referral coordination

Collaborates with patients, medical practitioners, and referring providers to support individualized care. Helps patients consider alternatives and coordinate ongoing treatment needs.

4 care stages · 2 guidelines · 0 courses · 0 providers

Training and supervision compliance

Operate only within the bounds of formal training, supervision, and site authorization. The protocol expects specialized training for facilitators, raters, and all staff interacting with participants or data.

1 care stage · 2 guidelines · 0 courses · 0 providers

Work within medically supervised settings

LSD-assisted psychotherapy in this study is explicitly framed as medically supervised. Therapists/facilitators need to practice within a setting capable of medical oversight and management of prolonged altered states.

2 care stages · 2 guidelines · 0 courses · 0 providers

Psychedelic research literacy and evidence appraisal

Teaches how to interpret the psychedelic clinical evidence base, compare strength of evidence across indications, understand mechanism theories, and critically appraise research claims. The competency supports evidence-informed practice rather than relying on general field narratives.

7 care stages · 1 guidelines · 9 courses · 7 providers

Benzodiazepine-support management

Use supportive anxiolytic or hypnotic medication only when allowed and clinically indicated. This requires careful judgment to balance comfort, safety, and preservation of the session’s integrity.

3 care stages · 1 guidelines · 0 courses · 0 providers

Clinician therapist availability and scope

At least one therapist in the dyad must be a clinician with capability to assess and manage medical or psychiatric adverse events during the dosing session. This reflects a required competency boundary between general support and clinical responsibility.

3 care stages · 1 guidelines · 0 courses · 0 providers

Deterioration triage and referral

Ability to judge clinical worsening over time and determine whether a participant can remain in the study or requires higher-level care. This is a continuing monitoring responsibility throughout the trial.

1 care stage · 1 guidelines · 0 courses · 0 providers

Dyadic facilitation and gender-balanced therapeutic presence

Experimental sessions are conducted by a male physician-investigator and an experienced female nurse, indicating competency in co-therapy, complementary roles, and continuous therapeutic presence.

1 care stage · 1 guidelines · 0 courses · 0 providers

Ibogaine-specific cardiac vigilance

Understand the unique cardiovascular hazards associated with ibogaine and the need for intensive cardiac oversight. The facilitator should know that cardiac risk is a central safety issue rather than a minor side effect.

2 care stages · 1 guidelines · 0 courses · 0 providers

Overdose recognition and response

Identify study-drug overdose and respond according to protocol with urgent sponsor notification and clinical monitoring. The protocol defines overdose as more than the assigned dose for that subject.

2 care stages · 1 guidelines · 0 courses · 0 providers

Participant preparation for medication adherence

Prepare participants to correctly use nicotine replacement therapy when assigned to the control arm. Facilitators must provide education, dosing instructions, and side-effect guidance.

2 care stages · 1 guidelines · 0 courses · 0 providers

Qualified psychiatric interview

Conducts a retrospective psychiatric interview to judge minimal clinical improvement on the current antidepressant regimen. Uses multiple information sources and clinical observation to determine whether the participant meets screening requirements.

1 care stage · 1 guidelines · 0 courses · 0 providers

Rescue medication judgment

Use rescue medications only after non-medical interventions have failed, and only by the study site-designated physician. Selection must consider local standard of care, subject history, and QTc risk.

1 care stage · 1 guidelines · 0 courses · 0 providers

Structured psychiatric screening collaboration

Understands the screening instruments and the respective roles of site staff and independent raters. The facilitator must collaborate with rater findings while maintaining appropriate boundaries and blinding.

1 care stage · 1 guidelines · 0 courses · 0 providers

Study-specific inclusion/exclusion vigilance

Confirm ongoing eligibility throughout the study and recognize conditions that require withdrawal or reassessment. Eligibility is not static and must be checked before key sessions.

3 care stages · 1 guidelines · 0 courses · 0 providers

Supportive management of MDMA session environment

Therapists must create and maintain a calm, supportive setting during MDMA administration. The session environment is intended to maximize comfort and facilitate therapeutic work while minimizing risk.

3 care stages · 1 guidelines · 0 courses · 0 providers

Case-based practice, peer consultation, and professional learning community

Teaches applied competence through role play, case discussion, peer consultation, seminars, mentorship, and learning-community structures. The emphasis is translating theory into practice, receiving feedback, and developing reflective clinical judgment with peers.

8 care stages · 0 guidelines · 6 courses · 6 providers

Psychedelic therapy foundation

Cluster covering 7 related competencies including: Psychedelic therapy foundation, Psychedelic therapy foundations, Psychedelic practice fundamentals.

4 care stages · 0 guidelines · 5 courses · 4 providers

Ethics and ethical practice

Cluster covering 4 related competencies including: Ethical practice, Ethics in psychedelic care, Ethics and ethical practice.

8 care stages · 0 guidelines · 4 courses · 3 providers

Professional application and practice development

Teaches practitioners how to translate psychedelic-informed training into professional practice, including applied skill development, scope awareness, practice-building considerations, and integration of competencies into real clinical or wellness settings.

4 care stages · 0 guidelines · 2 courses · 2 providers

Complex-case support and ethics-based clinical judgment

Teaches work with clinically complex contexts such as trauma, palliative care, and other nuanced presentations where ethical judgment, scope discipline, careful assessment, and individualized support are required.

3 care stages · 0 guidelines · 2 courses · 1 providers

Legal access pathways and care-team coordination

Teaches how participants move through lawful access routes and coordinated care pathways. The competency covers referral navigation, team handoffs, and the practical steps needed to connect eligible participants with appropriate treatment or study settings.

5 care stages · 0 guidelines · 2 courses · 1 providers

Psilocybin prescribing fundamentals

Cluster covering 2 related competencies including: Psilocybin prescribing fundamentals, Prescribing fundamentals for psychedelic treatment.

6 care stages · 0 guidelines · 2 courses · 1 providers

Clinical collaboration and compliance awareness

The page repeatedly emphasizes integrity, compliance, and collaboration with professional organizations and researchers. Learners are expected to practice within evolving regulatory and clinical standards.

1 care stage · 0 guidelines · 1 courses · 1 providers

Clinical trial training and feedback use

The page highlights best-in-class clinical training for drug trials and AI-supported evaluation. Learners are expected to refine skills quickly and receive targeted feedback in training or evaluation contexts.

8 care stages · 0 guidelines · 1 courses · 1 providers

Collaborative-care role awareness

The program emphasizes that it prepares people for therapeutic and facilitative roles within a collaborative care framework, not independent medical practice. Learners are expected to understand role boundaries, especially around prescribing and administration.

5 care stages · 0 guidelines · 1 courses · 1 providers

Compound comparison for therapeutic use

The course teaches learners to distinguish between classic psychedelics and emerging therapies within therapeutic applications. This is a foundational comparative literacy competency rather than a protocol-specific skill.

6 care stages · 0 guidelines · 1 courses · 1 providers

Contraindication and interaction review

The page explicitly notes medication interactions, contraindications, and risk management for prescribers. This indicates training in identifying unsafe combinations and excluding or delaying treatment when needed.

3 care stages · 0 guidelines · 1 courses · 1 providers

Ethical decision-making and confidentiality

The practicum explicitly says sites cover ethical considerations such as confidentiality, privacy, professional conduct, and ethical decision-making. Ethical alignment is also part of site approval.

2 care stages · 0 guidelines · 1 courses · 1 providers

Ethical grounding and integrity

The course repeatedly emphasizes ethical considerations, safety, and integrity in practice. Learners are expected to develop a grounded professional stance that respects legal boundaries and participant welfare.

3 care stages · 0 guidelines · 1 courses · 1 providers

Referral and further-training planning

The workshop provides recommendations for obtaining further training, signaling a competency in identifying next-step education and appropriate escalation pathways. This supports responsible scope-of-practice decisions.

1 care stage · 0 guidelines · 1 courses · 1 providers

Safety and legal boundaries awareness

The page includes explicit warnings about what graduates can and cannot legally do. Learners are expected to understand scope limits, licensure requirements, and when consultation supervision is needed.

3 care stages · 0 guidelines · 1 courses · 1 providers

Safety-oriented documentation and templates

Trainees receive templates such as consent and intake forms, informational documents, and guidelines, which implies competence in using standardized practice materials. The page also signals procedural support for safe and organized care delivery.

5 care stages · 0 guidelines · 1 courses · 1 providers

Sustainable practice development and prescriber coordination

The course teaches practical steps to launch and sustain a KAP practice, including forging relationships with prescribers and identifying suitable practicum sites. This is framed as part of professional development and business planning.

3 care stages · 0 guidelines · 1 courses · 1 providers

Use structured preparedness frameworks

The course is positioned as a preparedness-oriented training with self-directed preparation plus live facilitated learning. Learners are expected to internalize a framework for managing challenging or crisis moments with confidence and care.

2 care stages · 0 guidelines · 1 courses · 1 providers

General psychedelic-assisted practice skills

Catch-all cluster covering 189 general competencies for psychedelic-assisted clinical practice that did not group into a more specific category — including miscellaneous facilitation, monitoring, ethics, safety, regulatory awareness, group support, and program-specific skills not captured by dedicated clusters elsewhere.

8 care stages · 58 guidelines · 23 courses · 17 providers